Neolix Raises $600 million Series D
Neolix raised $600M in Series D financing. Neolix is a Digital Health company focused on meet growing domestic and international demand. The new capital is framed around meet growing domestic and international demand.
What it does
Neolix is a Digital Health company focused on meet growing domestic and international demand. The business sits in Healthcare & Life Sciences, where funded companies are using fresh capital to deepen product coverage, distribution, or operating capacity.
Traction
$600 million. Management framed the new capital around meet growing domestic and international demand.
Trend impact
Neolix aims to displace fragmented care delivery and legacy clinician workflow software with AI-enabled healthcare tooling. The capital raise matters because it gives the company more room to compete for customers, talent, and mindshare while incumbents and adjacent startups respond with clearer product depth or distribution.
Funding history
- October 23, 2025 · Series D · $600 million · undisclosed investors
Products & services
- Healthcare & Life Sciences workflow monitoring tied to the funding announcement
- Customer-facing product described on the company website
- Operational tooling for healthcare & life sciences teams
- Data capture and reporting across core business processes
- Team expansion support funded by the latest round